CD4 and neoplasm: In the last years preventive and therapeutic vaccination strategies using viral and tumor antigens (Ags) have been developed aiming at activation of naïve or expansion of spontaneous viral and tumor Ag-specific memory CD4+ T cells; leading to the first FDA approved therapeutic antitumor vaccine [5].